Aditum Bio
Aditum Bio is an investment adviser that reports to the SEC as exempt based in Oakland, CA. It reports advising 3 venture funds, with $773M in gross private fund assets as of its Form ADV filed Mar 31, 2026.
Focus
Not known yet. The SEC does not ask a firm what stages or sectors it invests in. Once the firm claims this profile, or rounds it invested in are recorded, it will show here with its source.
Portfolio
No rounds recorded yet. A round appears here when a press release, news report or the company names this firm as an investor, with a link to that source.
People
- Christian KleeManager of the General Partner of the IssuerLast named May 31, 2024
- Joseph JimenezManaging Director of the General Partner of the IssuerLast named May 31, 2024
- Joshua GertsmanManager of the General Partner of the IssuerLast named May 31, 2024
- Mark FishmanCo-Founder and Chairman of the Scientific Advisory BoardLast named May 31, 2024
- Praveena KandulaManaging Director of the General Partner of the IssuerLast named May 31, 2024
- Ilan ZipkinManaging Director of the General Partner of the IssuerLast named Jul 14, 2021
A fund's Form D names the executive officers and directors of its general partner when it is filed. People stay listed with the date they were last named; someone who has left may still appear until a newer filing or a correction says so.
Funds
| Fund | Formed | Raised | Target | Last filed |
|---|---|---|---|---|
| Aditum Bio Fund 3, L.P. | 2024 | — | $400M | May 31, 2024 |
| Aditum Bio Fund 2, L.P. | 2021 | — | $250M | Jul 14, 2021 |
Funds are matched to this firm by the manager named on their filings or by name. If a fund here is not theirs, tell us below.
Is something here wrong or out of date?
Tell us what has changed and, if you can, where it says so. An editor checks it against a source before the profile changes. If this profile is about your firm, you can also claim it and keep it current yourself.